Chinese General Practice ›› 2024, Vol. 27 ›› Issue (33): 4132-4138.DOI: 10.12114/j.issn.1007-9572.2024.0094
Special Issue: 女性健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2024-04-08
Revised:
2024-06-10
Published:
2024-11-20
Online:
2024-08-08
Contact:
ZHANG Jing
通讯作者:
张晶
作者简介:
作者贡献:
戴承晔进行研究的构思、设计以及文章撰写;邓毅凡进行数据的收集、整理与统计学分析;何胜虎、张晶负责文章的修订;张晶负责文章的质量控制及审校,对文章整体负责,监督管理。
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0094
指标 | ACS组(n=184) | 对照组(n=141) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄(岁) | 66.3±8.6 | 65.6±8.1 | 0.783 | 0.434 |
BMI(kg/m2) | 25.2±3.5 | 22.3±2.8 | 8.111 | <0.001 |
吸烟[例(%)] | 37(20.1) | 8(5.7) | 10.573a | 0.001 |
饮酒[例(%)] | 20(10.9) | 10(7.1) | 1.359a | 0.331 |
高血压[例(%)] | 98(53.3) | 47(33.3) | 12.829a | <0.001 |
糖尿病[例(%)] | 54(29.4) | 27(19.1) | 4.438a | 0.048 |
LVEF[M(P25,P75),%] | 61(56,62) | 62(60,63) | -3.157b | 0.002 |
TG(mmol/L) | 1.49±1.28 | 1.38±0.91 | 0.855 | 0.393 |
TC(mmol/L) | 4.72±1.05 | 4.58±1.07 | 1.141 | 0.255 |
HDL-C(mmol/L) | 1.12±0.27 | 1.37±0.29 | -8.123 | <0.001 |
LDL-C(mmol/L) | 3.02±0.77 | 2.28±0.79 | 8.455 | <0.001 |
单核细胞计数(×109) | 0.39±0.15 | 0.31±0.14 | 4.547 | <0.001 |
TSH(mU/L) | 2.67±1.01 | 1.79±0.73 | 9.109 | <0.001 |
MHR | 0.37±0.17 | 0.24±0.13 | 7.793 | <0.001 |
Table 1 Baseline data results of ACS group and control group
指标 | ACS组(n=184) | 对照组(n=141) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄(岁) | 66.3±8.6 | 65.6±8.1 | 0.783 | 0.434 |
BMI(kg/m2) | 25.2±3.5 | 22.3±2.8 | 8.111 | <0.001 |
吸烟[例(%)] | 37(20.1) | 8(5.7) | 10.573a | 0.001 |
饮酒[例(%)] | 20(10.9) | 10(7.1) | 1.359a | 0.331 |
高血压[例(%)] | 98(53.3) | 47(33.3) | 12.829a | <0.001 |
糖尿病[例(%)] | 54(29.4) | 27(19.1) | 4.438a | 0.048 |
LVEF[M(P25,P75),%] | 61(56,62) | 62(60,63) | -3.157b | 0.002 |
TG(mmol/L) | 1.49±1.28 | 1.38±0.91 | 0.855 | 0.393 |
TC(mmol/L) | 4.72±1.05 | 4.58±1.07 | 1.141 | 0.255 |
HDL-C(mmol/L) | 1.12±0.27 | 1.37±0.29 | -8.123 | <0.001 |
LDL-C(mmol/L) | 3.02±0.77 | 2.28±0.79 | 8.455 | <0.001 |
单核细胞计数(×109) | 0.39±0.15 | 0.31±0.14 | 4.547 | <0.001 |
TSH(mU/L) | 2.67±1.01 | 1.79±0.73 | 9.109 | <0.001 |
MHR | 0.37±0.17 | 0.24±0.13 | 7.793 | <0.001 |
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.431 | 0.408 | 12.317 | <0.001 | 4.185 | 1.881~9.307 |
高血压 | 0.824 | 0.232 | 12.626 | <0.001 | 2.279 | 1.447~3.590 |
糖尿病 | 0.562 | 0.268 | 4.383 | 0.036 | 1.754 | 1.036~2.968 |
LVEF | -0.766 | 0.349 | 4.827 | 0.028 | 0.465 | 0.235~0.921 |
BMI | 1.932 | 0.259 | 55.693 | <0.001 | 6.905 | 4.157~11.470 |
HDL-C | -1.919 | 0.256 | 56.243 | <0.001 | 0.147 | 0.089~0.242 |
LDL-C | 2.338 | 0.446 | 27.426 | <0.001 | 10.357 | 4.318~24.843 |
单核细胞计数 | 0.503 | 0.321 | 2.455 | 0.117 | 1.653 | 0.882~3.101 |
TSH | 1.897 | 0.251 | 57.154 | <0.001 | 6.667 | 4.077~10.902 |
MHR | 1.913 | 0.250 | 58.434 | <0.001 | 6.772 | 4.147~11.506 |
Table 2 Univariate Logistic regression analysis of ACS influencing factors in menopausal women
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.431 | 0.408 | 12.317 | <0.001 | 4.185 | 1.881~9.307 |
高血压 | 0.824 | 0.232 | 12.626 | <0.001 | 2.279 | 1.447~3.590 |
糖尿病 | 0.562 | 0.268 | 4.383 | 0.036 | 1.754 | 1.036~2.968 |
LVEF | -0.766 | 0.349 | 4.827 | 0.028 | 0.465 | 0.235~0.921 |
BMI | 1.932 | 0.259 | 55.693 | <0.001 | 6.905 | 4.157~11.470 |
HDL-C | -1.919 | 0.256 | 56.243 | <0.001 | 0.147 | 0.089~0.242 |
LDL-C | 2.338 | 0.446 | 27.426 | <0.001 | 10.357 | 4.318~24.843 |
单核细胞计数 | 0.503 | 0.321 | 2.455 | 0.117 | 1.653 | 0.882~3.101 |
TSH | 1.897 | 0.251 | 57.154 | <0.001 | 6.667 | 4.077~10.902 |
MHR | 1.913 | 0.250 | 58.434 | <0.001 | 6.772 | 4.147~11.506 |
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.185 | 0.543 | 4.764 | 0.029 | 3.271 | 1.129~9.478 |
高血压 | 0.892 | 0.335 | 7.067 | 0.008 | 2.439 | 1.264~4.707 |
糖尿病 | 0.174 | 0.393 | 0.197 | 0.657 | 0.840 | 0.389~1.814 |
LVEF | -0.632 | 0.515 | 1.505 | 0.220 | 0.532 | 0.194~1.458 |
BMI | 1.662 | 0.335 | 24.547 | <0.001 | 5.268 | 2.730~10.166 |
HDL-C | -1.113 | 0.359 | 9.630 | 0.002 | 0.328 | 0.163~0.664 |
LDL-C | 1.703 | 0.588 | 8.385 | 0.004 | 5.488 | 1.734~17.372 |
TSH | 1.895 | 0.332 | 32.578 | <0.001 | 6.652 | 3.470~12.751 |
MHR | 0.975 | 0.351 | 7.729 | 0.005 | 2.652 | 1.333~5.276 |
Table 3 Multivariate Logistic regression analysis of influencing factors of ACS in menopausal women
指标 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
---|---|---|---|---|---|---|
吸烟 | 1.185 | 0.543 | 4.764 | 0.029 | 3.271 | 1.129~9.478 |
高血压 | 0.892 | 0.335 | 7.067 | 0.008 | 2.439 | 1.264~4.707 |
糖尿病 | 0.174 | 0.393 | 0.197 | 0.657 | 0.840 | 0.389~1.814 |
LVEF | -0.632 | 0.515 | 1.505 | 0.220 | 0.532 | 0.194~1.458 |
BMI | 1.662 | 0.335 | 24.547 | <0.001 | 5.268 | 2.730~10.166 |
HDL-C | -1.113 | 0.359 | 9.630 | 0.002 | 0.328 | 0.163~0.664 |
LDL-C | 1.703 | 0.588 | 8.385 | 0.004 | 5.488 | 1.734~17.372 |
TSH | 1.895 | 0.332 | 32.578 | <0.001 | 6.652 | 3.470~12.751 |
MHR | 0.975 | 0.351 | 7.729 | 0.005 | 2.652 | 1.333~5.276 |
指标 | AUC | 95%CI | P值 | 最佳截断值 | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|---|---|
MHR | 0.777 | 0.725~0.830 | <0.001 | 0.255 | 76.1 | 72.3 |
TSH | 0.747 | 0.694~0.800 | <0.001 | 2.130 mU/L | 69.6 | 74.5 |
联合预测指标 | 0.810 | 0.764~0.857 | <0.001 | 0.513 | 77.7 | 73.0 |
Table 4 Diagnostic value of MHR,TSH and combined prediction of ACS in menopausal women
指标 | AUC | 95%CI | P值 | 最佳截断值 | 灵敏度(%) | 特异度(%) |
---|---|---|---|---|---|---|
MHR | 0.777 | 0.725~0.830 | <0.001 | 0.255 | 76.1 | 72.3 |
TSH | 0.747 | 0.694~0.800 | <0.001 | 2.130 mU/L | 69.6 | 74.5 |
联合预测指标 | 0.810 | 0.764~0.857 | <0.001 | 0.513 | 77.7 | 73.0 |
指标 | 低危亚组(n=59) | 中危亚组(n=64) | 高危亚组(n=61) | F值 | P值 |
---|---|---|---|---|---|
MHR | 0.29±0.11 | 0.36±0.15a | 0.45±0.19ab | 15.401 | <0.05 |
TSH(mU/L) | 2.27±1.06 | 2.61±0.90a | 3.11±0.92ab | 11.211 | <0.05 |
Table 5 Comparison of MHR and TSH levels in low-risk subgroup,medium-risk subgroup and high-risk subgroup
指标 | 低危亚组(n=59) | 中危亚组(n=64) | 高危亚组(n=61) | F值 | P值 |
---|---|---|---|---|---|
MHR | 0.29±0.11 | 0.36±0.15a | 0.45±0.19ab | 15.401 | <0.05 |
TSH(mU/L) | 2.27±1.06 | 2.61±0.90a | 3.11±0.92ab | 11.211 | <0.05 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. DOI:10.3760/cma.j.cn115791-20210221-00095.
|
[8] |
刘强. 血尿酸水平与冠心病及其严重程度相关性的研究[D]. 唐山:唐山华北理工大学,2023. DOI:10.27108/d.cnki.ghelu.2023.001356.
|
[9] |
张新超,于学忠,陈凤英,等. 急性冠脉综合征急诊快速诊治指南(2019)[J]. 临床急诊杂志,2019,20(4):253-262. DOI:10.13201/j.issn.1009-5918.2019.04.001.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[1] | WANG Zhijun, ZHANG Shibo, LIU Jie, LI Dongqi, ZHENG Meijia, ZHOU Jianzhi. Correlation Analysis between TyG-BMI Index and Nocturnal Hypertension in Patients with Hypertension [J]. Chinese General Practice, 2025, 28(18): 2212-2221. |
[2] | CHEN Yi, BAI Wenpei, LI Hongtian, WANG Yao, TIAN Zongmei, GU Bei, LIU Xiaohong, YANG Mukun. Construction of a Comprehensive Health Management Evaluation Indicator System for Menopausal Women [J]. Chinese General Practice, 2025, 28(14): 1781-1787. |
[3] | HUANG Chuanying, LIAO Xiaoyang, YANG Rong, LI Dongze, ZHANG Peng, JIA Yu, LIU Lidi. Interpretation of the Clinical Statement for Management of Female Cardiac Emergencies in 2024 [J]. Chinese General Practice, 2025, 28(12): 1427-1432. |
[4] | LUO Yuan, ZHANG Hua, WANG Sanxiang, ZHANG Mengxi, DENG Yuqian, RAN Haiye, LIU Jiaxin, ZHANG Yi, CHEN Xi, WU Yibo, ZHAO Liping. Development of a Comprehensive Fall Risk Assessment Tool for Older People in Elderly Care Institutions and Its Test [J]. Chinese General Practice, 2025, 28(04): 491-498. |
[5] | ZHANG Ming, WANG Wenjuan, HAO Wen, CHEN Jibin, XIA Wei, SHAO Yibing, WANG Bin. Clinical Research of Obstructive Sleep Apnea and Acute Coronary Syndrome: Current Status and Future Direction [J]. Chinese General Practice, 2025, 28(03): 257-261. |
[6] | ZHANG Gaoyu, WANG Zihan, GAO Xuefei, ZHANG Jin, DAI Tiangu, HE Qing, FAN Jiarong, HUANG Li, LI Lin. Research on the Development of a Risk Model for Coronary Heart Disease in Postmenopausal Hypertensive Women Based on the Triglyceride Glucose Index Combined with Vascular Elasticity Indicators [J]. Chinese General Practice, 2025, 28(01): 39-46. |
[7] | ZHANG Qiongdan, MAO Zhuoni, HUANG Dan, FANG Li. Correlation of Nucleolin with the Stability and Severity of Coronary Plaque in Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(36): 4561-4567. |
[8] | SUN Xuechun, DU Zhiyong, YU Huahui, LYU Qianwen, JIAO Xiaolu, WANG Yu, QIN Yanwen. Value of Lysophospholipid Metabolites in Prognosis of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: a Prospective Cohort Study [J]. Chinese General Practice, 2024, 27(36): 4540-4545. |
[9] | LIANG Hong, ZHANG Ying, XU Hanping, YE Aoxing, WU Lingling, ZHAO Jing. The Health Characteristics and Health Needs of Perimenopausal Women in the Community [J]. Chinese General Practice, 2024, 27(34): 4286-4294. |
[10] | ZUO Zhongqi, WANG Yu, JIN Yan, ZHANG Qingwei, YUAN Binbin, SHEN Saiya, WANG Fei, YU Man. Early Warning Assessment Tools for Cardiovascular Disease Risk: a Scoping Review [J]. Chinese General Practice, 2024, 27(27): 3440-3445. |
[11] | LI Yong, LI Zhanhu, JIN Bowei, LI Yuan, ZHANG Hongbo, SU Yakun, YAN Xiaoju. Correlation between Serum Complement C1q/Tumor Necrosis Factor-related Protein 5 Levels and the Severity of Coronary Artery Lesions and Myocardial Fibrosis Markers in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(27): 3365-3371. |
[12] | HU Guiping, LIN Ping, ZHAO Zhenjuan, WANG Yini, YAN Mingqiang, SUN Xiao. Relationship between Dietary Inflammatory Potential and Severity of Coronary Artery Disease in Acute Coronary Syndrome Patients [J]. Chinese General Practice, 2024, 27(24): 3000-3006. |
[13] | HE Junhui, WAN Daguo, DONG Jing, ZHANG Juan. Correlation Analysis between Pan-immune Inflammatory Value, Systemic Immune-inflammatory Index, and Vulnerable Plaques in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2024, 27(24): 2976-2981. |
[14] | HUANG Shuwei, ZHOU Zhiheng, FENG Tianyuan, LIU Li, DENG Guangpu, LI Yaotian, ZHU Hong. Study on the Predictive Value of Different Insulin Resistance Replacement Indices for Hyperuricemia in Middle-aged and Elderly Patients with Type 2 Diabetes [J]. Chinese General Practice, 2024, 27(19): 2364-2374. |
[15] | GONG Yue, HUANG Yueqing, ZHANG Liang, ZHAO Chunhua, HUANG Min. External Validation of a 10-year Cardiovascular Risk Assessment Tool Based on an Older Population [J]. Chinese General Practice, 2024, 27(19): 2336-2343. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||